Author:
Ariyoshi Yasunori,Shimahara Masashi,Tanigawa Nobuhiko,Tsuji Motomu
Publisher
Nihon University School of Dentistry at Matsudo Research Institute of Oral Science
Reference21 articles.
1. Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and Neck
2. 2. Lin JC, Jan JS, Hsu CY, Wong DY: High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin. Cancer, 85: 1430-1438, 1999.
3. 3. Jacobs JR, Pajak TF, Kinzie J, et al.: Induction chemotherapy in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg, 113: 193-197, 1987.
4. 4. Kish J, Drelichman A, Jacobs J, et al.: Clinical trial of Cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep, 66: 471-474, 1982.
5. 5. Yamamoto E, Kohana G, Sunakawa H, et al.: Mode of invasion Bleomycin sensitivity and clinical course in squamous cell carcinoma of the oral cavity. Cancer, 51: 2175-2180, 1983.